EU could pay over $10 billion for Pfizer and CureVac vaccines - source

The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.

Keywords
Τυχαία Θέματα